The Government of Karnataka has held discussions with senior leaders from Takeda Pharmaceutical Company on expanding the company’s Global Capability Centre (GCC) in Bengaluru and strengthening collaboration across the state’s life sciences and digital innovation ecosystem.
The meeting, hosted by the Department of Electronics, Information Technology and Biotechnology, focused on Karnataka’s strategy to position GCCs as centres for innovation, research and product development. Officials highlighted the state’s technology talent, biotechnology ecosystem and policy initiatives aimed at supporting global enterprises.
Takeda’s delegation, led by Lauren Duprey, Chief Transformation Officer, met with state officials, including Dr Manjula N., IAS, Secretary, Department of Electronics, Information Technology, Biotechnology and Science & Technology, along with representatives from the Karnataka Digital Economy Mission (KDEM) and the Bangalore Bioinnovation Centre.
The discussions covered opportunities to strengthen Takeda’s Bengaluru GCC, which supports the company’s global data, digital and technology operations in areas such as AI-driven drug discovery, digital health, software as a medical device, data science and manufacturing technologies.
The state government also highlighted its Katalyst initiative, a single-window facilitation programme for GCCs, as well as collaboration opportunities with research organisations including the Bangalore Bioinnovation Centre and C-CAMP.
“Karnataka has built a globally competitive ecosystem where Global Capability Centres are increasingly driving innovation, research, and digital transformation for enterprises across sectors,” said Dr Manjula N., IAS, Secretary, Department of Electronics, Information Technology, Biotechnology and Science & Technology.
The engagement forms part of Karnataka’s ongoing efforts to attract and expand high-value GCC investments in sectors including life sciences, biotechnology and digital health.